CCP
BSX icon

Corient Capital Partners’s Boston Scientific BSX Stock Holding History

Corient Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$594K Hold
15,947
– – 0.04% 302
2022
Q2 		$594K Sell
15,947
-4,362
-21% -$178K 0.05% 310
2022
Q1 		$899K Buy
20,309
+5,367
+36% +$233K 0.06% 261
2021
Q4 		$635K Sell
14,942
-2,661
-15% -$112K 0.04% 327
2021
Q3 		$764K Buy
17,603
+1,853
+12% +$82K 0.06% 265
2021
Q2 		$673K Buy
15,750
+2,745
+21% +$115K 0.05% 299
2021
Q1 		$502K Buy
13,005
+2,050
+19% +$77.6K 0.04% 318
2020
Q4 		$394K Sell
10,955
-23,501
-68% -$847K 0.04% 322
2020
Q3 		$1.32M Buy
34,456
+6,657
+24% +$257K 0.15% 132
2020
Q2 		$976K Buy
27,799
+17,499
+170% +$630K 0.12% 160
2020
Q1 		$336K Sell
10,300
-10,368
-50% -$405K 0.05% 275
2019
Q4 		$935K Buy
20,668
+6,542
+46% +$274K 0.12% 180
2019
Q3 		$575K Buy
14,126
+2,671
+23% +$113K 0.08% 238
2019
Q2 		$492K Sell
11,455
-576
-5% -$22.2K 0.08% 239
2019
Q1 		$462K Buy
12,031
+4,337
+56% +$166K 0.08% 233
2018
Q4 		$272K Buy
+7,694
New +$279K 0.05% 270

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Corient Capital Partners's BSX Position: Q3 2022 in Review

Corient Capital Partners held its Boston Scientific (BSX) position steady in Q3 2022 at 15,947 shares worth $594K. The position accounts for 0.04% of the portfolio, ranked #302.

Corient Capital Partners first reported a position in BSX in Q4 2018 and has held it in 16 quarters since. The position peaked at $1.32M in Q3 2020. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Corient Capital Partners held 15,947 shares of Boston Scientific worth $594K as of Q3 2022.
  • Corient Capital Partners left its Boston Scientific share count unchanged in Q3 2022.
  • Boston Scientific made up 0.04% of Corient Capital Partners's portfolio in Q3 2022, its #302 holding.
  • Corient Capital Partners first reported a position in Boston Scientific in Q4 2018 and has held it in 16 quarters since.
  • Corient Capital Partners's Boston Scientific position peaked at $1.32M in Q3 2020.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.